PLA2G2A and bacterial infectious disease: Thus, our results validate PLA2 toxins with membrane-disturbing activities as a source of promising dual-target therapeutic peptides that might be useful in the development of new treatments for cancer and bacterial infections, including those caused by MDR strains.